Susan Weinkle, MD
Dermatology · Bradenton, FLNPI 1992897938
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $95,925 of the $103,332 with a category attached, or 92.8%. AbbVie accounts for 65.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $36,308 and has fallen 99.6% since, to $162 in 2025. Among dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $826.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$67K
- Galderma Laboratories, L.p.$23K
- Dermira, Inc.$6K
- Merz North America, Inc.$4K
- Almirall LLC$2K
- Revance Therapeutics, Inc.$214
- plus $463 from 11 others
Across 194 payments — averaging $6551.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.3M
What the payments were for
- Consulting fees$95,92593%
- Speaking & faculty fees$2,5002%
- Travel & lodging$1,4181%
- Food & beverage$3,4363%
- Education$530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $67,455 |
| Galderma Laboratories, L.p. | 32 | $22,981 |
| Dermira, Inc. | 5 | $5,622 |
| Merz North America, Inc. | 3 | $4,397 |
| Almirall LLC | 1 | $2,200 |
| Revance Therapeutics, Inc. | 5 | $214 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $77 |
| Sun Pharmaceutical Industries Inc. | 4 | $70 |
| Amgen | 1 | $63 |
| Bioventus LLC | 1 | $59 |
| Boehringer Ingelheim | 2 | $47 |
| Biofrontera Inc. | 2 | $46 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $26 |
| Organogenesis Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Aclaris Therapeutics, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$103,332 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 47 | $2,556 |
| Triamcinolone Acetonide | 145 | $995 |
| Metronidazole | 11 | $719 |
| Minoxidil | 74 | $675 |
| Doxycycline Hyclate | 32 | $478 |
| Mometasone Furoate | 32 | $434 |
| Betamethasone Dipropionate | 15 | $364 |
| Cephalexin | 66 | $358 |
| ValacyclovirValacyclovir Hcl | 12 | $302 |
| Spironolactone | 28 | $90 |
| Mupirocin | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bradenton
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.